Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis

Bepotastine besilate 1.5% solution is an H(1)-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular itching associated with allergic conjunctivitis. Several clinical studies have demonstrated its safety as well as its efficacy versus placebo. This re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wingard, Jeremy B, Mah, Francis S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046989/
https://www.ncbi.nlm.nih.gov/pubmed/21386912
http://dx.doi.org/10.2147/OPTH.S8665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046989/
https://www.ncbi.nlm.nih.gov/pubmed/21386912
http://dx.doi.org/10.2147/OPTH.S8665

Ejemplares similares